Skip to main navigation Skip to search Skip to main content

Antigenic Sites in Carcinoembryonic Antigen

  • Sten Hammarstrom
  • , John E. Shively
  • , Raymond J. Paxton
  • , Barbara G. Beatty
  • , Ake Larsson
  • , Rahul Ghosh
  • , Ole Bormer
  • , Franz Buchegger
  • , Jean Pierre Mach
  • , Pierre Burtin
  • , P. Seguin
  • , Bruno Darbouret
  • , F. Degorce
  • , J. Sertour
  • , J. P. Jolu
  • , Abraham Fuks
  • , Holger Kalthoff
  • , Wolff Schmieget
  • , Rudiger Arndt
  • , Gunter Kloppel
  • Sabine von Kleist, Fritz Grunert, Klaus Schwarz, Yuji Matsuoka, Masahide Kuroki, Christoph Wagener, Teddy Weber, Akira Yachi, Kohzoh Imai, Noriyuki Hishikawa, Masayuki Tsujisaki
  • Umeå University
  • Comprehensive Cancer Center at the City of Hope
  • Stockholm University
  • Rikshospitalet-Radiumhospitalet HF
  • University of Lausanne
  • Institut de Neurosciences de la Timone, Centre National de la Recherche Scientifique - Aix-Marseille University
  • Oris Industrie
  • McGill University and Génome Québec Innovation Centre
  • University Medical Center Hamburg-Eppendorf
  • University of Freiburg
  • Fukuoka University
  • RWTH Aachen University
  • Medix Biochemica
  • Sapporo Medical School

Research output: Contribution to journalArticlepeer-review

171 Scopus citations

Abstract

The epitope reactivities of 52 well-characterized monoclonal antibodies (Mabs) against carcinoembryonic antigen from 11 different research groups were studied using competitive solid-phase immunoassays. About 60% of all possible combinations of Mabs as inhibitors and as the primary binding antibody were investigated. The inhibition data were analyzed by a specially developed computer program “EPITOPES” which measures concordance and discordance in inhibition patterns between Mabs. The analysis showed that 43 of the 52 Mabs (83%) could be classified into one of five essentially noninteracting epitope groups (GOLD 1–5) containing between four and 15 Mabs each. The epitopes recognized by the Mabs belonging to groups 1 to 5 were peptide in nature. With one or two possible exceptions non-classifiable Mabs were either directed against carbohydrate epitopes (4 Mabs) or were inactive in the tests used. Within epitope groups GOLD 1, 4, and 5 two partially overlapping subgroups were distinguished. Mabs with a high degree of carcinoembryonic antigen specificity generally belonged to epitope groups GOLD 1 and 3.

Original languageEnglish
Pages (from-to)4852-4858
Number of pages7
JournalCancer Research
Volume49
Issue number17
StatePublished - 1 Sep 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Antigenic Sites in Carcinoembryonic Antigen'. Together they form a unique fingerprint.

Cite this